A laboratory method for determination of overall haemostatic potential in plasma. I. Method design and preliminary results

Thrombosis Research

Volumn 96, Issue 2, 1999, Pages 145-156

  He, Shu ^a   Bremme, Katarina ^b   Blombäck, Margareta ^a  

^a Dept of Lab Med/Coagul Research ^*  (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Fibrin generation; Fibrin lysis; Haemostasis; Laboratory method

Indexed keywords

FIBRIN; FIBRINOGEN; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBRIN FORMATION; FIBRINOLYSIS; HEMOSTASIS; HUMAN; LABORATORY; MENOPAUSE; METHODOLOGY; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; SPECTROPHOTOMETRY; VON WILLEBRAND DISEASE;

ADULT; AGED; ANTICOAGULANTS; BLOOD COAGULATION DISORDERS; FEMALE; FIBRIN; HEMOSTASIS; HUMANS; INFANT, NEWBORN; LABORATORY TECHNIQUES AND PROCEDURES; MASS SCREENING; MIDDLE AGED; PLATELET COUNT; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; REFERENCE VALUES; RESEARCH DESIGN; TIME FACTORS;

EID: 0032753063     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00092-4     Document Type: Article

References (20)

1. Macfarlane R.G. An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature. 202:1964;498-499.
2. Newland J.R. Blood coagulation. A review Am J Obstet Gynecol. 156:1987;1420-1422.
3. Williams S., Fatah K., Ivert T., Blombäck M. The effect of acetylsalicylic acid on fibrin gel lysis by tissue plasminogen activator. Blood Coag Fibrinol. 6:1995;718-725.
4. Davey D.A., MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol. 158:1988;892-898.
5. Blombäck M., Eneroth P., Landgren B.M., Lagerström M., Anderson O. On the intraindividual and gender variability of haemostatic components. Thromb Haemost. 67:1992;70-75.
6. Andersson O., Blombäck M., Bremme K., Wramsby H. Prediction of changes in levels of haemostatic variables during natural menstrual cycle and ovarian hyperstimulation. Thromb Haemost. 77:1997;901-904.
7. Hubbuch A., Adema E., Gebert U., Herz R. Multicentre evaluation of Tina-quant D-dimer, a latex based reagent for BM/Hitachi Systems. Klin Lab. 41:1995;383-386.
8. Pelzer H., Schwarz A., Stuber W. Determination of human prothrombin activation fragment 1+2 in plasma with an antibody against a synthetic peptide. Thromb Haemost. 65:1991;153-159.
9. Pelzer H., Schwartz A., Heimburger N. Determination of human thrombin antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost. 59:1988;101-106.
10. Silveira A.M.V., Yamamoto T., Adamson L., Hessel B., Blombäck B. Application of an enzyme-linked immunosorbent assay (ELISA) to von Willebrand factor (vWF) and its derivatives. Thromb Res. 43:1986;91-102.
11. Rosén S., Andersson M., Blombäck M., Hägglund U., Larrieu M.J., Wolf M., Boyer C., Rothschild C., Nilsson I.M., Sjörin E., Vinazzer H. Clinical application of a chromogenic substrate method for determination of factor VIII activity. Thromb Haemost. 54:1985;818-823.
12. Chmielewska J., Wiman B. Determination of tissue plasminogen activator and its "fast" inhibitor in plasma. Clin Chem. 32:1986;482-485.
13. Vermylen C., de Vreker R.A., Verstraete M. A rapid enzymatic method for assay of fibrinogen fibrin polymerization time (FPT test). Clin Chem Acta. 8:1963;418-424.
14. Doolittle R.F. The molecular biology of fibrin. Stamatoyannopoulos G., Nienhuis A.W., Majerus P.W., Varmus H. The Molecular Basis of Blood Diseases. 1994;701-723 W.B. Saunders Company, Philadelphia.
15. Hemker H.C. Thrombin generation, an essential step in haemostasis and thrombosis. Bloom A.L., Forbes C.D., Thomas D.P., Tuddenham E.G.D. Haemostasis and Thrombosis. 1994;477-490 Churchill Livingstone, Edinburgh.
16. Hemker H.C., Wielders S., Kessels H., Beguin S. Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential. Thromb Haemost. 70:1993;617-624.
17. Hellgren M., Blombäck M. Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. Gynecol Obstet Invest. 12:1981;141-154.
18. Bremme K., Östlund E., Almqvist I., Heinonen K., Blombäck M. Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium. Obstet Gynecol. 80:1992;132-137.
19. Greer I.A. Pathological processes in pregnancy-induced hypertension and intrauterine growth retardation. "an excess of heated blood" Greer I.A., Turpie A.G.G., Forbes C.D. Haemostasis and Thrombosis in Obstetrics and Gynecology. 1992;163-202 Chapman & Hall Medical, London.
20. He S., Bremme K., Blombäck M. Acquired deficiency of antithrombin in association with a hypercoagulable state and impaired function of liver and/or kidney in preeclampsia. Blood Coag Fibrinol. 8:1997;232-238.